Published in Cancer Weekly, July 7th, 2009
"The CDC cell lines were assessed using microarray-based comparative genomic hybridization and chemosensitivity testing. The CDC cells grew in vitro as an adherent monolayer...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2009-07-07)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.